logo

For the Inventor, By the Inventor

San Marcos, CA, United States of America

Kyle S Jones

This inventor holds 6 USPTO granted patents and 13 published patent applications. Top assignees: Inhibrx Biosciences, Inc., Phylaxis Bioscience, LLC. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyle S Jones. Retrieved from https://idiyas.com/inventor/kyle-s-jones-6vt6sji3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 7.6

ph-index = 1


Company Filing History:

goldMedal6 out of 11 
 
Inhibrx Biosciences, Inc.
 patents
silverMedal1 out of 1 
 
Phylaxis Bioscience, LLC
 patent
where one patent can have more than one assignee

Years Active: 2024-2025

Loading Chart...
6 patents (USPTO):Explore Patents
1. 12331126 - OX40-binding polypeptides and uses thereof (2025-06-17),
2. 12234297 - IgE binding proteins and uses thereof (2025-02-25),
3. 12227584 - Multivalent and multispecific OX40-binding fusion proteins (2025-02-18),
4. 12195533 - Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the same (2025-01-14),
5. 12187804 - Multivalent and multispecific 41BB-binding proteins (2025-01-07),
6. 12084502 - CD33-binding polypeptides and uses thereof (2024-09-10),

Title: The Innovative Contributions of Kyle S. Jones

Introduction

Kyle S. Jones is a prominent inventor based in San Marcos, California. He has made significant contributions to the field of biotechnology, holding a total of six patents. His work primarily focuses on polypeptides and their applications in modulating biological activities.

Latest Patents

Among his latest patents is the development of OX40-binding polypeptides and their uses. This patent provides VHH-containing polypeptides that bind OX40, with some embodiments focusing on those that agonize OX40. Additionally, he has patented IgE-binding proteins and their uses, which include VHH domains, polypeptides, and proteins that modulate the biological activity of IgE.

Career Highlights

Kyle has worked with notable companies in the biotechnology sector, including Inhibrx Biosciences, Inc. and Phylaxis Bioscience, LLC. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in the industry.

Collaborations

Some of his coworkers include Brendan P. Eckelman and John C. Timmer, who have collaborated with him on various projects.

Conclusion

Kyle S. Jones continues to be a driving force in the field of biotechnology through his innovative patents and collaborations. His work has the potential to significantly impact the understanding and treatment of various biological conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…